Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada

Links shared publicly online about this topic.

  • 900
    total visits

Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada

medicalnewstoday.com —

Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery plat

View full resource at medicalnewstoday.com

Tags: Pain, Pharma, Phase 3 Clinical Trial

  • Share

Most Recently Shared on September 3, 2010 at 2:00 pm By:

mnt_clinical MNT Clinical Trials

Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada http://mnt.to/3Jfc

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Pharma News MNT Pharma News

MNT Pain News MNT Pain News

Advertisement